Synnat Pharma Private Limited

Synnat Pharma Private Limited - pharma in Serilingampally, Telangana, India. FY 2026 financials and compliance.
CIN U24232TG2011PTC074746 Incorporated 31 May 2011 ROC Hyderabad HQ Serilingampally, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹71.34 Cr
▲ 12.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹6.6 Lakh
Issued & subscribed
Open charges
₹25 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Employees · EPFO
189
Latest available

About Synnat Pharma Private Limited

Data last updated: 14 December 2025

Synnat Pharma Private Limited is a private limited company based in Serilingampally, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 31 May 2011, the company has been in operation for over 15 years.

Registered with ROC Hyderabad under CIN U24232TG2011PTC074746.

Capital: an authorised share capital of ₹3 Cr and a paid-up capital of ₹6.6 Lakh. It is led by directors including Siddharth Karnani and Ramesh Kumar Karnani.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Serilingampally, Telangana.

As per the financials filed for FY 2024, the company reported a revenue of ₹71.34 Cr, a growth of 12% compared to the previous year.

The company has a workforce of approximately 189 employees as per the latest available data.

The company is associated with 1 brand - Synnat Pharma. As per MCA filings, the company has open charges of ₹25 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website synnatpharma.com.

Company Details of Synnat Pharma Private Limited
CIN U24232TG2011PTC074746
Registration Number 074746
Incorporation Date 31 May 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    3Rd Floor Tower – 2 (Eastern Side), Vamsirams Jyothi Granules Kondapur, Serilingampally, Telangana, India – 500084
  • Industry
    Pharma, Drug Formulation & Development
Company report
Synnat Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Synnat Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Synnat Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Synnat Pharma Private Limited

Synnat Pharma Private Limited has one previous CIN (Corporate Identification Number): U24232AP2011PTC074746. The current CIN is U24232TG2011PTC074746, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24232TG2011PTC074746 Current
U24232AP2011PTC074746 Previous

Associated Brands with Synnat Pharma Private Limited

Synnat Pharma Private Limited operates one associated brand: Synnat Pharma. These brands represent Synnat Pharma Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures active pharmaceutical ingredients and intermediates for global markets. synnatpharma.com

Competitors & Alternatives of Synnat Pharma Private Limited

Brands and companies operating in the same space as Synnat Pharma Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases. Hellerup, Denmark, Denmark 2007
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Synnat Pharma Private Limited

Synnat Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Synnat Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Synnat Pharma Private Limited

Synnat Pharma Private Limited is audited by AGARWAL MAHESWARI & CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
AGARWAL MAHESWARI & CO Locked Locked Locked
Premium access

Complete auditor history for Synnat Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Synnat Pharma Private Limited

Synnat Pharma Private Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Siddharth Karnani Director 03 Dec 2022 3 Years 7 Months Current
Ramesh Kumar Karnani Director 31 May 2011 15 Years 1 Months Current
Karnani Ritesh Director 03 Dec 2022 3 Years 7 Months Current

Financials of Synnat Pharma Private Limited FY 2024 filings available

Synnat Pharma Private Limited reported revenue of ₹71.34 Cr (up 12.00% YoY) for FY 2024.

Revenue · FY 2024
₹71.34 Cr ▲ 12.00%
Premium access

Ten-year financial statements for Synnat Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Synnat Pharma Private Limited

Premium access

Shareholding and ownership data for Synnat Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Synnat Pharma Private Limited

Open charges
₹25 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹25.00 Cr
Latest charge details
DateLenderAmountStatus
30 Aug 2025 Others ₹10 Cr Open
30 Aug 2025 Others ₹15 Cr Open

Total charge records: 2 View all charges

Employees and EPFO Compliance at Synnat Pharma Private Limited

Synnat Pharma Private Limited has a workforce of 189 employees as of Mar 29, 2024.

Employee count
189
Active EPFO establishments
1
Employee growth
35.97%
Premium access

Employee and EPFO history for Synnat Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Synnat Pharma Private Limited

Premium access

GST registrations and filing compliance for Synnat Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Synnat Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Synnat Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Synnat Pharma Private Limited

Premium access

MSME payment history for Synnat Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Synnat Pharma Private Limited

Premium access

Corporate group structure for Synnat Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Synnat Pharma Private Limited

Premium access

MCA filings and documents for Synnat Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Synnat Pharma Private Limited

Charges
30 Aug 2025
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101166436 was registered on 30 Aug 2025.
Charges
30 Aug 2025
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101166435 was registered on 30 Aug 2025.
Activity
30 Sep 2024
Synnat Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Synnat Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Directors
03 Dec 2022
Siddharth Karnani was appointed as a Director on 03 Dec 2022 & has been associated with this company since 3 years 7 months.
Directors
03 Dec 2022
Karnani Ritesh was appointed as a Director on 03 Dec 2022 & has been associated with this company since 3 years 7 months.

Frequently Asked Questions about Synnat Pharma Private Limited

Synnat Pharma Private Limited is an active private limited company in the pharma sector based in Serilingampally, Telangana, India. It was incorporated on 31 May 2011 (15+ years old) and is registered under CIN U24232TG2011PTC074746. The company has 189 employees.

Synnat Pharma Private Limited reported revenue of ₹71.34 Cr for FY 2024 (up 12.00% YoY).

The current directors of Synnat Pharma Private Limited are:

The primary industry of Synnat Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Synnat Pharma Private Limited can be reached at the registered office: 3Rd Floor Tower – 2 Eastern Side, Vamsirams Jyothi Granules Kondapur, Serilingampally, Telangana, India – 500084, or through the website synnatpharma.com.

The authorised capital is ₹3 Cr, and the paid-up capital is ₹6.6 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available